drugset / Trial / NCT02529631

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

NCT02529631

Completed 64 enrolled Certmedica International GmbH
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This trial compares two treatment methods: 1. Orlistat 60 mg to be taken three times daily one capsule; indicated for weight loss in overweight adults. Important is also that it is taken along with a reduced-calorie and low-fat diet. 2. Polyglucosamine tablets to be taken two times daily two tablets, taken with the two main meals with the highest fat content, indicated for weight maintenance and weight loss.

Timeline

Start
2009-11
Primary completion
2010-06
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Orlistat Small molecule 60 mg Oral

Indications